AstraZeneca to buy U.S.-based CinCor Pharma in $1.8 billion deal

Peoria, IL, USA 102.7 Super Hits

(Reuters) – AstraZeneca said on Monday it will acquire U.S.-based clinical-stage biopharmaceutical company CinCor Pharma Inc in a deal valued at about $1.8 billion.

(Reporting by Radhika Anilkumar in Bengaluru; Editing by Savio D’Souza)

Amazon must negotiate with Staten Island warehouse workers, NLRB says

1h ago

Diaz, Howard officially declared winners in Peoria Public Schools board races

15m ago

US Army chief of staff asked to step down by Hegseth, sources say

1h ago

Appeals panel orders resentencing of ex‑Colorado clerk over voting machines

26m ago

Starbucks closes China deal with Boyu, plans to expand stores

26m ago

Energy-price surge will work through economy slowly, Fed's Williams tells Fox Business

33m ago

Peoria | WPBG-HD2 | 1027superhits.com

Now Playing

102.7 Super Hits

Loading Songs

No feed items available at this time.

Pause Auto-Update | Back to Top

AstraZeneca to buy U.S.-based CinCor Pharma in $1.8 billion deal

Current Weather »

Peoria, IL

102.7 Super Hits on FB